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ABSTRACT 
OBJECTIVE:  To evaluate the  diagnostic  validity  of breast MRI in  discriminating benign from 
malignant lesions in women with occult breast lesions who are at a high risk of developing breast 
cancer, with histopathologic findings and/or follow up used as the reference standard. 
 PATIENTS  AND  METHODS:  Contrast-enhanced  bilateral  breast  MRI  was  performed  on  100 
women  at  high  risk  of  developing  breast  cancer  with  indeterminate  imaging  findings  by 
mammography  and/or  ultrasonography.  Lesions  detected  by  MRI  that  could  represent  potential 
malignancies in both breasts were evaluated. Morphologic assessment and kinetic analysis (contrast 
enhancement  and  time/intensity  curves)  were  performed  on  each  lesion  using  dedicated 
postprocessing and display software. Functional MR tools were used in about 60% of cases to help in 
the differential diagnosis between malignant and benign of suspicious lesions detected at conventional 
MRI. 
 RESULTS: Among 100 patients included in the study12% of the patients were finally diagnosed as 
free of any pathology, 56% had benign findings, while 31% of the patients were malignant. (24 IDC, 
4 Invasive Lobular Carcinoma, 1 Medullary carcinoma, 1 Mucinous carcinoma and 1 DCIS.) The 
sensitivity, specificity, positive and negative predictive values of CE-MRI, were 100%, 93%, 86%, 
and 100% respectively. Overall accuracy of MRI breast was 95%. CONCLUSION: Breast MRI is 
highly effective in detection and characterization of occult breast lesions in high risk population, with 
excellent sensitivity and high specificity. Development of functional MRI tools contributed to the 
improving validity of this modality 
INTRODUCTION 
Breast  cancer  is  the  most  common 
malignancy that affects women worldwide and 
is  a  significant  health  care  problem.  Several 
well-established  clinical  imaging  modalities 
have  been  in  use  to  study  the  architecture, 
physiology  and  function  of  breast  cancer. 
Methods  such  as  X-ray  mammography, 
ultrasound and physical examination are often 
limited in sensitivity and specificity, especially 
in  young  women.  MRI  is  increasingly  being 
used  for  preoperative  local  staging, 
localization of multiple lesions and screening 
of  high-risk  patients  (Jagannathan,  2009). 
The standard breast MRI examination uses a 
gadolinium  contrast agent  to  highlight  lesion 
and  their  extent.  In  the  assessment  of  breast 
cancer,  measurements  are  usually  acquired 
dynamically before, during and at certain time 
points  after  bolus  injection  of  the  contrast 
agent, allowing the contrast agent uptake and 
washout  characteristics  of  the  lesion  to  be 
characterized.    Evaluation  is  based  on  the Role of MRI in Characterization of Occult Breast Lesions…. 
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uptake curve from regions of interest defined 
within the enhancing parts of the lesion and on 
the  morphology  of the lesion  (Leach, 2009). 
MR imaging of the breast is noninvasive and 
uses no ionizing radiation. Its primary benefit 
is high sensitivity, the highest of any imaging 
technique  for  breast  lesions,  high  soft-tissue 
contrast, multiplanar sectional imaging and 3-
D rendering, the ability to detect small volume 
residual tumor and measurement of lesion size 
that  corresponds  with  pathological 
measurement.  Use  of  dynamic  contrast-
enhanced  MR  helps  to  noninvasively  image 
the  microvascular  network  of  tumors  to 
determine if they are benign or malignant and 
to map functional parameters of breast lesions 
(Odle, 2006) The acquisition of 3D MRI data 
allows  assessment  of  lesion  morphology  and 
contrast  enhancement  (tumor  kinetics) 
regardless  of    breast  size  or  architecture 
(Wiener et al, 2005) Morphology arises from 
the  high  spatial  resolution  afforded  by  MR 
imaging and deals with how the lesion looks, 
while  kinetic  features  arise  from  temporal 
resolution  or  dynamic  imaging  and  address 
how  the  lesion  handles  contrast  uptake  and 
washout (Odle, 2006). 
Breast MRI has a very high sensitivity 
of  greater  than  or  equal  to  90%  for  breast 
cancer.  Studies  of  the  use  of  breast  MRI  in 
high risk groups, have reported a specificity of 
93 to 99% (Lo and Cheung, 2008). Clinical 
indications for breast MRI include analysis of 
indeterminate  breast  lesions,  screening  of 
women  with  high  genetic-familial  risk, 
preoperative staging, evaluation of response to 
chemotherapy  (Schmitz  et  al,  2008), 
evaluating  the  extent  of  disease  in  women 
diagnosed with breast cancer, identification of 
multicentric and multifocal disease (Friedman 
et al, 2008), differentiating between scar tissue 
and  recurrent  cancer,  examining  breasts  that 
contain  implants  and  diagnosis  of  metastatic 
breast  cancer  with  unknown  primary  origin 
(Macura  et  al,  2006).  An  increased  risk  for 
breast cancer can be due to a personal history 
of breast cancer; a history of a breast biopsy, 
with “borderline” biologic behaviour such as 
radial  scar,  lobular  carcinoma  in  situ,  or 
atypical  ductal  hyperplasia;  a  history  of 
mediastinal irradiation for Hodgkin disease; a 
familial  history  of  breast  and/or  ovarian 
cancer; or genetic mutations. For all of these 
subgroups,  breast  MR  imaging  has  been 
successfully  used  to  help  detect 
mammographically and sonographically occult 
breast  cancer  (Kuhl,  2007).  In  the  current 
study we investigated the diagnostic accuracy 
of breast MRI in  discriminating benign from 
malignant lesions in women with occult breast 
lesions  who are at a high risk  of  developing 
breast cancer, with histopathologic findings or 
follow  up  used  as  the  reference  standard  for 
comparison. 
PATIENTS AND METHODS 
This study included 100 female patients 
referred  to  perform  Contrast-enhanced 
bilateral breast MRI at Ain Shams University 
hospitals and private radiological centres. All 
patients were at high risk of developing breast 
cancer with normal or indeterminate imaging 
findings  by  mammography  and/or 
ultrasonography.   
Exclusion criteria included: Caroline Habib et al 
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The  following  patients  were  excluded 
from the current study: 
1.  Patients  with  bad  general  condition  and 
renal impairment.  
2. Lactating and pregnant females.  
3. Patients known to have contraindications for 
MRI  e.g.  an  implanted  magnetic  device, 
pacemakers, claustrophobia.  
All patients were subjected to complete 
clinical  and  radiological  evaluation 
assessment.  This  involved  thorough  history 
taking  including  personal  history,  especially 
with  respect  to  previous  breast  cancer  or 
biopsies with benign histology,  family history 
of  breast  or  ovarian  cancer,  abnormalities 
suspicious of malignancy (e.g., palpable mass, 
skin  retraction,  nipple  discharge),  hormonal 
status  and  previous  allergic  reaction  after 
administration  of  MR  contrast  material. 
Previous  imaging  studies  such  as 
mammography  and/or  sonography,  and  their 
findings  were  evaluated  and  recorded.  Then 
contrast-enhanced  bilateral  breast  MRI  was 
performed  and  results  of  MRI  examination 
were  compared  to  the  findings  from 
histopsthology and/or follow up.  
Patient  preparation:  There  is  no 
specific preparation for different MR imaging 
such  as  fasting.  When  possible,  MRI 
examination  of  the  breast  in  premenopausal 
women was scheduled to be performed in the 
second  or  third  week  of  the  cycle,  unless 
urgent. For application of the contrast material, 
a venous line (18–20 G) was inserted before 
starting  the  examination.  Every  patient  was 
screened for ferromagnetic objects, implanted 
medical  devices,  surgical  clips,  metal 
fragments  in  or  near  the  eyes,  and  other 
metallic  objects.  All  metallic  objects  were 
removed from the patient's body  
Scan  protocol:  MR  imaging  was 
performed  with  Philips  superconductive 
magnet  system  operating  at  1.5  Tesla  using 
breast surface coils. The patient lies prone on 
the  examination  couch  with  her  breast(s) 
positioned  dependent  in  the  receiver  breast 
coil(s)  and  the  arms  placed  along  the  body. 
Appropriate IV anesthetic agents were given to 
some  patients  who  feared  the  MRI  machine 
when  needed.  IV  contrast  (gadolinium 
chelates)  was  given  for  assessment  of  tumor 
kinetics. Dose given was about 0.2 ml/kg body 
weight.  Spine-echo  T1  WI  was  performed 
after  contrast  administration.    The  routine 
protocol applied  in this study included  Axial 
T1,  T2,  Axial  T2  fat  suppressed,  STIR  or 
SPAIR  ±  Sagittal  STIR,  Axial  Post-contrast 
T1 WI fat suppressed ± Sagittal Post-contrast 
3D  TFE  (T1  WI).  Dynamic  3D  multiphase 
post-contrast  study  was  done  in  6-8  minutes 
with MIP reconstruction (once before contrast 
and  4-5  times  after  contrast,  each  around  1 
minute).  For  any  region  of  interest  (ROI), 
Time-Signal intensity curves were performed. 
Signal intensity measurements were performed 
prior  to  as  well  as  following  contrast 
administration in this region of interest (ROI). 
ROIs  are  drawn  at  the  point  of  maximum 
enhancement.  Diffusion  weighted  imaging  + 
ADC calculation were utilized in 59 cases. The 
field of view (FoV) typically ranged from 280 
to 340 mm, depending on the breast size. The 
slice thickness was 3 mm or sometimes 2mm, 
and  without  gaps.  Perfusion  imaging  was Role of MRI in Characterization of Occult Breast Lesions…. 
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performed  in  2  cases  and  MR  Spectroscopic  imaging was performed in 10 cases. 
Table (1) Physical parameters of different pulse sequences. 
   
Axial T1WI 
 
Axial T2WI 
 
Axial/ Sagittal STIR 
Axial/ Sagittal +c 
T1WI Fat sat 
TR  540  4000-4800  2000-7500  485 
TE  10  120  55-170  10 
NEX  1  1  1  1 
ST  3mm  3mm  3mm  3mm 
Gap  0  0  0  0 
FOV  34x34cm  34x34cm  34x34cm  34x34cm 
Matrix  256x160 
or 256x192 
256x160 
or 256x192 
256x160 
or 256x192 
256x160 
or 256x192 
 
TR: Repetition time TE: Echo time NEX: Number of acquisition FOV: Field of view STIR: Short time 
inversion recovery Fat sat: Fat saturation ST : Slice thickness. 
 
Data interpretation: 
All  lesions  or  areas  of  abnormal 
enhancement  detected  by  MRI  that  could 
represent  potential  malignancies  in  both 
breasts  were  evaluated,  by  experienced  MR 
radiologist, as regard:  
  Morphology 
  Exact Location  
  Extent of involvement 
  Signal  intensity  on  different  pulse 
sequences 
  Kinetics;  Enhancement  pattern  and 
time/intensity curves 
  Vascularity of the lesion 
ACR BI-RADS–MRI Lexicon was used 
as a guideline for data collection. According to 
the  BI-RADS  Lexicon  of  the  American 
College  of  Radiology,  suspicious  enhancing 
areas  in  the  breast  are  differentiated  into  (a) 
focus/foci,  (b)  masses,  or  (c)  areas  of  non-
mass-like enhancement. Moreover, associated 
findings are described (Fischer, 2010). Masses 
and  areas  of  non-mass  like  enhancement  are 
subjected  to  careful  analysis  of  their 
morphology, enhancement kinetics, and signal 
intensity  patterns  on  T1-  and  T2-weighted 
images (Lehman et al, 2005 and Kuhl, 2007). 
A  focus  is  a  small  isolated  spot  of 
enhancement, generally less than 5 mm in size, 
that is so tiny that no  definitive morphologic 
descriptors  can  be  applied  (Fischer,  2010, 
Lehman et al, 2005 and Kuhl, 2007). A mass 
is a three-dimensional space-occupying lesion 
that  may  or  may  not  displace  or  otherwise 
affect the surrounding normal tissue. For the 
evaluation  of  masses,  different  criteria  are 
described.  Criteria  include  shape,  margin, 
endotumoral  type  of  contrast  internal 
enhancement,  and  the  initial  and  post-initial 
signal  behavior  in  relation  to  the  precontrast 
signal. Non-mass-like  lesions  on MRI  of the 
breast  are  enhancing  areas  that  are  neither  a Caroline Habib et al 
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focus nor a mass. Non-mass-like enhancement 
descriptions  included  distribution,  internal 
enhancement and symmetry. It is described as 
a focal area, linear, ductal, segmental, regional, 
multiple  regions,  or  diffuse.  Internal 
characteristics  of  the  enhancing  area,  like 
homogeneous,  heterogeneous, 
stippled/punctuate,  clumped,  or 
reticular/dendritic, is evaluated (Fischer, 2010 
and Lehman et al, 2005). Associated findings 
(such as edema, adenopathy, cysts, and skin or 
chest  wall  involvement)  are  reported  and 
kinetic  curve  assessment  of  all  lesions 
described.  The  analysis  of  enhancement 
kinetics  included  initial  peak  (Early  phase) 
enhancement and delayed-phase enhancement 
analyses, by measuring the signal intensity in 
region  of  interest  (ROI),  and  tracking  its 
course  over  the  dynamic  series  (time–signal 
intensity  curve).  ROIs  were  placed  into  the 
area  that  exhibits  strongest  enhancement  on 
the  first  postcontrast  image.  Early  Post-
contrast  Phase  enhancement  describes  the 
steepness of the first part of the kinetic curve, 
indicating the velocity and degree with which 
enhancement  occurs  and  may  be  slow, 
medium, or rapid. Delayed phase enhancement 
refers  to  signal  intensity  changes  that  occur 
immediately  after  the  early  signal  intensity 
increase  which  may  (a)  decline  again;  (b) 
exhibit  a  sharp  bend  and  plateau;  or  (c) 
continue to rise after the early phase, yielding 
persistent  enhancement.  Enhancing  nodules 
were  assumed  to  be  almost  malignant  when 
they  showed  early  intense  enhancement  and 
progressive  signal  loss  over  time  (washout), 
whereas  lesions  showing  progressive 
enhancement  over  time  were  assigned  to  be 
more likely benign (Kuhl, 2005). (Fig. 1) 
 
Fig. 1 Different phases of the signal time course of a dynamic series and the respective kinetic criteria. We 
distinguish three phases: (1) initial post-contrast phase (injection of contrast agent until the second post-contrast 
minute), (2) post-initial phase (second through third post-contrast minute), (3) late post-contrast phase (4th 
through 8th poscontrast minute). In the postinitial and late postcontrast phase, the time course of signal intensity 
is rated visually according to the following scheme: Type Ia (“persistent enhancement”). Type Ib (“persistent 
with bowing”). Type II (“plateau curve”). Type III (“washout curve”) (Kuhl, 2005). 
 
Using  ACR  BI-RADS–MRI  Lexicon, 
lesions were categorized into seven categories 
according to the  findings  of the breast MRI. 
MRM-BI-RADS  0  describe  an  incomplete 
assessment and the category MRM-BIRADS 6 
is  given  to  a  histological  verified  breast 
carcinoma. The other five categories include:  
Category  MRM-BI-RADS  1:  “negative”  No 
abnormal  enhancement  is  found.  Category Role of MRI in Characterization of Occult Breast Lesions…. 
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MRM-BI-RADS  2:  “benign”  MRI  shows  a 
benign  finding,  for  example  a  hyalinized 
nonenhancing  fibroadenoma,  cysts,  and  old 
nonenhancing  scars,  fat-containing  lesions 
such  as  oil  cysts,  lipomas,  galactoceles,  or 
mixed-density hamartomas.  Category MRM-
BI-RADS 3: “probably benign” Changes that 
are highly unlikely to be malignant, i.e., those 
that  have  a  very  high  probability  of  being 
benign, are placed in this category. Category 
MRM-BI-RADS  4:  “suspicious”  These  are 
lesions  that  do  not  have  the  characteristic 
morphology of breast carcinoma, but do have a 
definite low to moderate probability of being 
malignant.  Category  MRM-BI-RADS  5: 
“highly  suggestive  of  malignancy”  Lesions 
categorized as MRM-BI-RADS 5 have a high 
probability of being cancerous. They show the 
typical  findings  of  a  malignant  breast  tumor 
(Fischer, 2010). 
Results 
A  total  of  100  high  risk  females 
presented  with  occult  breast  lesions  were 
included  in  the  study.  Cases  included  in  the 
study  ranged  from  22  to  67  years  old  with 
mean  age  of  43.7  years.  38.7%  of  the 
malignant  cases  were  aged  from  41  to  50 
years,  25.8%  from  31  to  40  years  old  and 
35.5% were ≥51.  
Clinical  data:  Palpable  breast  masses 
was the most common clinical presentation (31 
patients, 31%) among the study population, 28 
patients (28%) were asymptomatic, 29 patients 
(29%)  were  referred  for  follow  up  post-
surgery, 3 patients (3%) had skin changes, 3 
patients  (3%)  complained  of  breast 
enlargement,  3  patients  (3%)  had  enlarged 
axillary  lymph  nodes,  2  patients  (2%)  had 
nipple  discharge  and  only  one  patient  (1%) 
complained  of  breast  pain.  Positive  family 
history of breast cancer was the most common 
risk  factor  encountered  in  the  studied  group 
(38%).  Other  risk  factors  were;  history  of 
previous breast cancer (29%), personal history 
of another malignancy such as endometrial or 
ovarian cancer (6%), biopsy-proven diagnosis 
of proliferative breast disease, atypia, lobular 
carcinoma in situ or radial scar (9%), increased 
breast  densities  in  mammography  relative  to 
age  (11%)  and  late  first  term  pregnancy  or 
nulliparity (7%). 
Histopathology  findings  and  follow 
up: Among the 100 patients with occult breast 
lesions  included  in  this  study  31  patients 
(31%) turned  out to be  malignant, 2 patients 
had  multicenteric  malignant  lesions  and  4 
patients  had  2  malignant  lesions  either 
epsilateral or contralateral. 56% (56 patients) 
of the studied  lesions  were benign; 52 cases 
had  various benign pathologies, (hyperplasia, 
fibrocystic  disease,  fibroadenoma,  benign 
postoperative  changes),  3  cases  had  benign 
Phylloids  tumour  and  1  case  was  Intraductal 
pappiloma. 13 cases (13%) were diagnosed as 
free of pathology. The histopathalogical types 
of the 35  malignant biopsies (taken from 31 
patients)  in  our  study  were  as  following:  24 
cases  IDC  (77.4%),  4  cases  invasive  lobular 
carcinoma  (13%),  one  case  medullary 
carcinoma  (3.2%),  one  case  mucinous 
carcinoma (3.2%) and one case DCIS (3.2%). 
The  commonest  location  of  the  malignant 
masses  within  the  breast  tissue  was  in  the Caroline Habib et al 
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upper  outer  quadrant,  where  51.4%  of  the 
lesions were located. 
Mammographic results: The results of 
the  mammographic  examinations  of  the 
patients  were;  38%  of  the  studied  cases  had 
dense  breasts  in  mammography  which 
hindered  proper  assessment  of  the  breast 
masses,  7%  showed  normal  mammography 
with  no  masses  detected,  31%  were 
categorized as BIRADS III (probably benign), 
3%  were  categorized  as  BIRADS  IV  and  V 
(probably malignant and highly suspicious of 
malignancy),  21%  were  described  as  having 
irregular  densities  for  further  assessment. 
Among the 38 cases that had dense breasts, 12 
cases turned out to have underlying malignant 
masses,  9  cases  had  underlying  benign 
pathologies and the rest (17 cases) were free. 
All  these  lesions  were  readily  identified  in 
MRI. The sensitivity, specificity, positive and 
negative  predictive  values  of  mammography 
were found to be 51.6%, 88.4%, 66.7%, and 
80.3%  respectively.  Overall  accuracy  of 
mammography was 77%.  
 
Table (2) Distribution of the studied group as regards the mammographic findings 
%  No   Variables  
7%  7  NAD 
38%  38  Dense breast (non conclusive) 
31%  31  Probably Benign (BIRADIII) 
3%  3  Probably malignant  (BIRAD IV & V) 
21%  21  Irregular asymmetric densities 
100%  100  Total 
 
Table  (3)  Comparison  between  mammography  versus  histopathology  and  follow  up  among  the 
studied group  
P   Pathology  
Benign                   Malignant  
Mammography  
>0.05 
NS 
15 (48.4%)  61 (88.4%)  Probably  Benign  and 
Dense breast 
16 (51.6%)  8 (11.6%)  Probably Malignant 
This table shows no statistically significant association between mammography and pathology by using chi-
square test. P value >0.05 insignificant 
 
Table (4) Validity of mammography in case of breast lesions among the studied cases: 
 
 
 
 
 
 
%  Variables  
51.6%  Sensitivity  
88.4%  Specificity  
66.7%  PPV 
80.3%  NPV 
77%  Accuracy  Role of MRI in Characterization of Occult Breast Lesions…. 
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MRI  results:  The  results  of  the  MRI 
examinations of the patients were; 64% of the 
studied  cases  were  benign,  BIRADII  and 
BIRADIII, by MRI criteria and 36% of cases 
were suggestive of malignancy by MRI criteria 
(BIRADIV  and  BIRADV).  Among  the  36 
cases  diagnosed  by  MRI  as  malignant,  5 
turned  out  to  be  benign  by  histopathological 
evaluation (false positive), while among the 64 
cases diagnosed by MRI to be benign lesions, 
none  were  proved  to  be  malignant  by 
histopathological  evaluation  (no  false 
negative) The sensitivity, specificity, positive 
and  negative  predictive  values  of  MRI  for 
occult  breast  lesions  in  high  risk  patients 
included in the study, were found to be 100%, 
93%,  86%,  and  100%  respectively.  Overall 
accuracy of MRI breast was 95%.  
 
Table (5) Distribution of the studied group as regard MRI findings  
 
 
 
 
 
 
 
 
Table (6) Comparison between MRI versus histopathology and follow up among the studied group  
P   X
2  Pathology  
Benign                   Malignant  
MRI 
<0.001 
S 
47  0  64(93%)  Benign 
 
31(100%)  5(7%)  Malignant 
 
This table shows statistically significant association between MRI and pathology by using chi-square 
test. P value <0.01 significant  
Table (7) Validity of MRI in characterization of breast lesions among the studied cases  
 
 
 
 
 
 
%  No   Variables  
45%  45  Benign (BIRADII) 
19%  19  Probably Benign (BIRADIII) 
 
9% 
7% 
11% 
 
9 
7 
11 
BIRADIV  
A 
B 
C 
9%  9  BIRADV 
%  Variables  
100%  Sensitivity  
93%  Specificity  
86%  PPV 
100%  NPV 
95%  Accuracy  Caroline Habib et al 
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This table shows that MRI is considered better positive predictor for cancer breast in relation to the 
pathology with higher sensitivity than specificity but general speaking it is considered highly valid 
with high specificity also.  
 
Fig. 2.: A column chart for comparison between validity of mammography versus MRI 
 
DISCUSSION 
Detection of breast cancer is the primary 
aim  of  breast  imaging.  The  combination  of 
decreased  mammographic  sensitivity  and 
increased prevalence of breast cancer in denser 
breasts  has  prompted  interest  in  the 
investigation  of  supplemental  screening  with 
ultrasound  or  MRI  (Shafqat  et  al,  2011).  
Although  increasing  age  is  the  single  most 
important  risk  factor  for  developing  breast 
cancer  (Bevers,  2008),  yet  the  rate  at  which 
risk rises declines significantly around age 50 
years.  Therefore  breast  cancer  incidence  in 
high  risk  population  is  higher  in  relatively 
younger age groups than in general population 
(Spicer  and  Pike,  2005).  This  was  reflected 
among  our  study  population  who  were  all 
chosen to be of high risk of breast cancer, and 
so around 65% of cancer cases were presented 
in  the  31-50  years  age  group  (38.7%  of  the 
malignant  cases  were  presented  in  the  41-50 
years  age  group  and  64.5%  presented  in  the 
31- 50 age group). 
Until  recently,  the  use  of  breast  MR 
imaging  for  screening  was  greatly 
discouraged. This has changed, in that MR is 
increasingly  used  for  screening  in  selected 
subsets of  women  with an  increased  lifetime 
risk  for  breast  cancer  (Kuhl,  2007).  We 
decided  to  choose  the  patients  in  this  study 
among the high risk population, because many 
studies proved that MRI is a highly sensitive 
test for detecting breast cancer, however it is 
not  recommended  for  screening  women  at 
average  risk.  So  it  has  been  proposed  as 
adjunct screening for women with a high risk, 
such  as  genetic  predisposition,  to  breast 
cancer. Mammography has lower sensitivity in 
this group, detecting fewer than half the breast 
cancers diagnosed (Houssami et al, 2009). A 
meta-analysis  of  five  studies  of  MRI  as  an 
adjunct  to  conventional  imaging  in  high-risk 
women has provided convincing evidence that 
MRI detects additional cancers, compared with 
mammography  alone  (Houssami  et  al,  2009 
and Lord et al, 2007). MRI is more sensitive 
than mammography in screening women with 
suspected or proven inherited mutations of the 
breast cancer genes. The addition  of MRI  in 
screening  this  population  detects  8–24 
0% 
20% 
40% 
60% 
80% 
100% 
120% 
Sensitivity  Specificity  PPV  NPV  Accuracy 
MRI 
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additional cancers per 1000 screens, but also 
increases a woman’s risk of being recalled for 
investigation  or  surgical  biopsy  for  false-
positive findings (Leach et al, 2005, Warner 
et al, 2004 and Sardanelli et al, 2007)  
Subgroups  in  the  population  with  an 
elevated risk of breast cancer can be identified 
by performing genetic testing for breast cancer 
predisposition  mutations  or  by  evaluating 
family  history  (Leach,  2009).  High-risk 
populations  include  women  with  known  or 
suspected  gene  mutations,  women  with  first-
degree  relatives  who  are  known  mutation 
carriers,  and  those  with  a  family  history 
suggesting  inherited  mutations  (Houssami  et 
al, 2009). An increased risk for breast cancer 
can also be due to a personal history of breast 
cancer;  a  history  of  a  breast  biopsy,  with 
“borderline” biologic behavior such as radial 
scar,  lobular  carcinoma  in  situ,  or  atypical 
ductal  hyperplasia;  a  history  of  mediastinal 
irradiation  for  Hodgkin  disease;  a  familial 
clustering of breast and/or ovarian cancer; or 
dense  breast  composition.  For  all  of  these 
subgroups,  breast  MR  imaging  has  been 
successfully  used  to  help  detect 
mammographically and sonographically occult 
breast cancer (Friedman et al, 2008 and Kuhl, 
2007).  In the current study we identified high 
risk  patients  by  evaluating  the  personal  and 
family  history.  Positive  family  history  of 
breast cancer was the most common risk factor 
encountered in the studied group (38%).  
Bleiweiss et al (2005) stated that the two 
main histologic types of invasive carcinoma of 
the  breast  are  invasive  duct  carcinoma  and 
invasive  lobular  carcinoma.  Together  they 
constitute  the  vast  majority  of  infiltrative 
malignancies  that  will  be  encountered  in 
routine  practice.  Van  de  Vijver  (1999)  
mentioned  the  estimated  frequency  of  each 
histologic  type  of  invasive  breast  cancer; 
Invasive  Ductal  carcinoma  (not  otherwise 
specified)  70%,  Invasive  Lobular  carcinoma 
10%,  Tubular  carcinoma  5%,  Mucinous 
carcinoma  5%,  Medullary  carcinoma  3%, 
Atypical Medullary carcinoma 3% and others 
4%. In general this coincides with the results 
of our study; where IDC was the most frequent 
histopathological  type  encountered  in  the 
study malignant cases. (24 cases IDC (77.4%), 
4 cases invasive lobular carcinoma (13%). 
Of all breast imaging techniques that are 
currently  available,  including  mammography, 
breast US, positron emission tomography, and 
scintimammography,  MR  offers  the  highest 
sensitivity  for  invasive  breast  cancer. 
Published  sensitivity  levels  range  between 
89% and 100%. In all studies that can be found 
in the literature, the sensitivity of MR imaging 
was  higher  than  that  of  mammography.  The 
degree  to  which  the  sensitivities  of 
mammography and breast MR imaging differ 
in  the  same  patients  depend  on  the 
mammographic breast density and the type of 
breast  cancer:  The  difference  increases  with 
increasing breast density and for cancers that 
are  difficult  to  diagnose  on  the  basis  of 
mammographic  findings.  The  sensitivity  of 
breast  MR  imaging  is  not  impaired  by  the 
amount or density of the fibroglandular tissue 
nor  by  scar  tissue,  radiation  therapy,  or 
prosthetic  breast  implants  or  other  types  of 
breast  reconstruction  (Kuhl,  2007). Caroline Habib et al 
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Overlooking  invasive  breast  cancer  on  MR 
images  is  rare,  but  it  certainly  does  happen. 
Non-enhancing  invasive  breast  cancers  are 
exceedingly  rare.  More  often,  the  reason  for 
failure to diagnose invasive cancer with breast 
MR imaging is early and strong enhancement 
in  the  surrounding  normal  fibroglandular 
tissue  that  may  mask  the  enhancing  cancer 
(Kuhl, 2007). 
In the current study, among the 38 cases 
that had  dense breasts by  mammography, 12 
cases turned out to have underlying malignant 
masses,  9  cases  had  underlying  benign 
pathologies and the rest (17 cases) were free. 
All  these  lesions  were  readily  identified  in 
MRI. Therefore our results agree with Morrow 
et  al  (2011)  who  stated  that,  compared  with 
mammography,  MRI  has  a  higher  sensitivity 
for  the  detection  of  breast  cancer  and  is  not 
affected by breast density. Also these findings 
agree  with  previous  studies  that  have 
cumulatively  evaluated  breast  MRI  in  more 
than 1000 high-risk patients and found that the 
technique identified cancer that was not seen 
on  mammography  in  4  percent  of  cases 
(Liberman, 2004). 
In  our study population the sensitivity, 
specificity,  positive  and  negative  predictive 
values  of  mammography  were  found  to  be 
51.6%, 88.4%, 66.7%, and 80.3% respectively. 
Overall accuracy of mammography was 77%. 
X-ray  mammography  (XRM)  is  an  effective 
screening  method  in  the  normal  population, 
particularly  in  those  over  50,  showing  a 
sensitivity  of  about  86%.  However,  with  the 
early  onset  of  disease  in  the  high-risk 
population,  there  is  a  need  to  screen  at  a 
younger  age,  where  the  higher  proportion  of 
breast  parenchyma  can  result  in  dense 
mammograms  that  are  hard  to  interpret. 
Several studies (Kerlikowske et al, 1996 and 
Mushlin et al, 1998) have shown that, in the 
normal population, the sensitivity of screening 
mammograms  falls  with  age  (Leach,  2009). 
This explains the lower sensitivity achieved by 
mammography  in  this  study  high  risk 
population. (51.6%)  
Most  of  the  previous  studies  showed 
that  the  sensitivity  of  MR  imaging  for 
detection  of  breast  cancer  is  very  high,  and 
approaches  100%  for  invasive  carcinoma. 
However  the  specificity  is  lower  and  varies 
widely between different studies. The factors 
associated with this wide range of specificity 
are  differences  in  the  study  population, 
strength  of  magnet,  imaging  protocols,  and 
interpretation criteria (Bedrosian et al, 2003). 
In their study, Baltzer et al (2010) stated that 
false  positive  findings  occur  and  lead  to 
unnecessary  biopsy  and  concluded  that  non-
mass  lesions  were  the  major  cause  of  false-
positive  breast  MRI  findings.  Therefore  the 
basic  drawback  of  this  modality  was  low 
specificity  for  breast  malignancy.  Multiple 
studies,  including  the  current  study,  have 
shown  that  with  the  improvement  in 
equipment  and  technique  there  is  gradual 
increase in specificity (Shafqat et al, 2011). 
A  number  of  prospective  single-  or 
multicenter  trials  have  been  conducted  to 
evaluate the role of MR imaging in screening 
high risk population. The results of all these 
studies are concordant in that early diagnosis 
of  cancer  is substantially improved  if MR  is Role of MRI in Characterization of Occult Breast Lesions…. 
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included in the surveillance program. Cancers 
were  diagnosed  at  a  prognostically  favorable 
stage, with published sensitivity levels ranging 
between  79%  and  98%.  As  a  result,  MR 
imaging is now accepted as an integral part of 
surveillance  programs  in  women  with 
suspicion  of  familial  breast  cancer  (Kuhl, 
2007). The data regarding the specificity and 
positive predictive value for screening MR are 
less concordant: A higher rate of false-positive 
diagnoses  for  MR  imaging  than  for 
mammography  has  been  reported  in  several 
studies (Leach et al, 2005, Warner et al, 2004 
and Kriege et al, 2004). The study by Warner 
et  al  (2004)  provides  a  possible  explanation 
for this: Whereas the rate of false positive MR 
diagnoses  was  high  at  the  beginning  of  the 
breast  MR  screening  project,  the  rate 
decreased from year to year to reach the same 
level  as  that  for  mammography,  where 
mammography  and  MR  exhibited  equivalent 
positive predictive values. This observation, as 
well as the results from  other studies (Kuhl, 
2005, Stoutjesdijk et al, 2001 and Trecate et 
al,  2003)  suggests  that  a  high  rate  of  false-
positive  diagnoses  is  not  inherent  to  the 
technique of breast MR imaging. Rather, it is 
due to limited experience with breast MR in a 
screening setting (Kuhl, 2007).
  
In our study the sensitivity, specificity, 
positive and negative predictive values of MRI 
for occult breast lesions in high risk patients 
included in the study, were found to be 100%, 
93%,  86%,  and  100%  respectively.  Overall 
accuracy of MRI breast was 95%. Among the 
36  cases  diagnosed  by  MRI  as  malignant,  5 
turned  out  to  be  benign  by  histopathological 
evaluation (false positive), while among the 64 
cases diagnosed by MRI to be benign lesions, 
none  were  proved  to  be  malignant  by 
histopathological  evaluation  (no  false 
negative).  Therefore  breast  MRI  had  higher 
sensitivity  than  specificity  but  general 
speaking  it  is  considered  highly  valid  with 
high specificity also. We found that combining 
qualitative  assessment  of  morphological 
appearance  of  lesion  on  post  contrast  study 
and  time  signal  intensity  curves  with 
functional  MR  tools,  which  were  utilized  in 
about 60% of the study population, was useful 
for achieving high validity for breast MRI. 
Our results  are  comparable  to  most  of 
studies done in the past; Shafqat et al (2011) 
performed  a  retrospective  analysis  on  70 
patients who underwent MRI breast because of 
suspicious  mammographic  abnormalities,  yet 
not  essentially  high  risk  patients.  The 
sensitivity,  specificity,  positive  and  negative 
predictive  values  of  MRI  for  breast  lesions 
was found to be 94 %, 85%, 90%, and 82% 
respectively. Overall accuracy  of MRI breast 
was 90%. There have been a number of studies 
that  have  investigated  MRI  and 
Mammography  for  screening  women  at  high 
familial  risk  of  breast  cancer.  A  study 
performed by Kuhl et al (2000) included 192 
patients with 12 detected cancers. They found 
that the sensitivity of breast MRI was 100% 
versus  33%  for  mammography,  while  MRI 
specificity  was  95%  versus  93%  for 
mammography. Results of Podo et al (2002) 
are  much  similar;  sensitivity  and  specificity 
were 100% and 99% for MRI respectively and 
13% and 100% for Mammography.  Tilanus-Caroline Habib et al 
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Linthorst et al (2000) conducted another study 
on 109 patients. They detected 3 cancer cases 
that were all seen on MRI. MRI sensitivity and 
specificity were 100% and 94% respectively. 
One  year  later  Stoutjesdijk  and  colleagues 
(2001) performed a study on a population of 
179 women with high risk of breast cancer. 14 
cancers  were  detected  with  sensitivity  and 
specificity  100%  and  93%  respectively  for 
MRI  and  42%  and  96%  for  mammography.  
Another  study  performed  by  Warner  et  al 
(2001),  achieved  lower  values  as  regard  the 
validity  of  MRI;  sensitivity  and  specificity 
were  86%  and  91%  for  MRI  respectively 
versus  43%  and  99%  for  Mammography. 
Morris  and  co-workers  (2003)  described  a 
group of 367 high risk women, retrospectively. 
MRI  detected  14  more  malignancies  than 
mammography.  The  study  performed  by 
Kriege et al (2004) recruited women with no 
previous  history  of  breast  cancer  in  several 
risk groups. The study included 1909 women, 
age  ranging  between  19-72  years.  Fifty 
cancers  were  detected,  with  a  sensitivity  of 
71% for MRI, 40% for XRM (mammography), 
and  89%  for  the  combined  techniques.  MRI 
specificity  was  89.8%  and  XRM  specificity 
95.0%.    Although  this  study  published  by 
Kriege et al (2004) showed a relatively high 
percentage  of  breast  cancers  that  were  false-
negative  on  MR  images  but  were  diagnosed 
due only to mammographic abnormalities, this 
high rate was not observed in the other trials 
(Kuhl, 2007). Also our study didn’t agree with 
Kriege  et  al,  (2004)  there  was  no  false 
negative  on  MRI  imaging  among  the 
malignant  cases  diagnosed  in  our  study 
population.  Warner  et  al  (2004)  performed 
another study and screened 236  women  with 
gene  mutations,  including  women  with  a 
personal  history  of  breast  cancer,  finding  22 
cancers.  The  sensitivity  was  77%  for  MRI, 
36%  for  XRM,  and  86%  for  both.  The 
specificity was 95.4% for MRI and 99.8% for 
XRM.  In a single-centre study conducted by 
Kuhl et al (2005), 529 women with a life time 
risk of at least 20%, including women with a 
personal  history  of  breast  cancer,  were 
screened  for  a  mean  period  of  5  years;  43 
cancers were found. Screening included MRI, 
XRM  and  ultrasound,  with  sensitivities  of 
91%, 33% and 40%, respectively. Combining 
MRI and XRM gave an overall sensitivity of 
93% for the whole population and 100% in the 
group without a personal risk of breast cancer. 
Specificity of MRI (97.2%) was equivalent to 
that of mammography (96.8%) Mammography 
alone, and also mammography combined with 
breast ultrasound, seemed insufficient for early 
diagnosis of breast cancer in women who are 
at increased familial risk. They concluded that 
if MRI is used for surveillance,  diagnosis of 
intraductal and invasive familial or hereditary 
cancer is achieved with a significantly higher 
sensitivity and at a more favorable stage. The 
UK  Magnetic  Resonance  Imaging  in  Breast 
Cancer  Screening  (MARIBS)  study, 
performed  by  Leach  et  al  (2005),  compared 
MRI  with  mammography  (XRM)  in  a 
prospective  non-randomised  trial  in  women 
with  at  least  50%  risk  of  carrying  gene 
mutations  based  on  direct  testing  or  family 
history. MRI was almost twice as sensitive as 
XRM in this high-risk group (77% vs 40%); Role of MRI in Characterization of Occult Breast Lesions…. 
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although  the  specificity  of  MRI  was  lower 
(81% vs 93%). These results show that MRI 
has  considerably  greater  sensitivity  for  the 
detection  of  breast  cancer  than  XRM  in  this 
risk group. Lehman et al (2005) performed a 
multicenter study, 390 women with a lifetime 
risk  of  more  than  25%,  including  previous 
cancer, received a single screen, detecting six 
cancers.  Sensitivity  was  not  assessed, 
however,  MRI  detected  all  cancers,  XRM 
detected  two,  and  ultrasound  one.    Another 
multi-centre study conducted by Sardanelli et 
al  (2007),  screened  278  women  at  high-risk, 
including  previous  cancer.  Eighteen  cancers 
were  detected,  giving  an  MRI  sensitivity  of 
94%, compared with sensitivities of 59% for 
XRM,  65%  for  ultrasound,  and  50%  for 
clinical  breast  examination.    In  a  study  by 
Hagen  et  al  (2007)  491  tested  mutation 
carriers  received  861  screens.  MRI  was 
compared  with  XRM.  Twenty-five  cancers 
were detected, giving a sensitivity of 86% for 
MRI  and  48%  for  XRM.    In  a  single-centre 
study  performed  by  Riedl  et  al  (2007),  327 
women  with  a  high  familial  risk  of  breast 
cancer, including a previous personal  history 
of breast cancer for some, participated in 672 
screening rounds. Twenty-eight cancers  were 
detected, with sensitivities of 85.7% for MRI, 
50% for XRM, and 42.9% for ultrasound. The 
specificity  was  92%  for  MRI  and  98%  for 
XRM.  Despite  the  differences  in  the  study 
populations  and  methods  used,  the  studies 
show the same trends. MRI was invariably a 
more  sensitive  technique  than  XRM,  and 
combining the techniques provided an overall 
sensitivity of about 90 % (Riedl et al, 2007).
 
Our  results  agreed  well  with  these 
studies mainly as regard the high sensitivity of 
MRI,  however  our  results  shows  100% 
sensitivity and higher specificity which is also 
more than specificity of mammography. This 
could  be  attributed  to  using  functional  MRI 
tools, mainly diffusion weighted images which 
was done in about 60% of the cases and helped 
to a great extent in highlighting the pathology 
among the normal enhancing glandular tissues. 
None  of  the  above  mentioned  studies 
conducted  on  high  risk  population  utilized 
such functional tools; they mainly depend on 
morphological  and  kinetic  assessment  of  the 
breast  lesions.  Yoshikawa  et  al  (2007) 
performed a study to investigate breast cancer-
detecting  ability  of  diffusion  weighted 
magnetic  resonance  imaging  (DW-MRI)  by 
comparing the breast cancer detection rates of 
DW-MRI  and  mammography  in  48  women 
who had breast cancer (53 cancer lesions). The 
breast  cancer  detection  rates  by  MMG  and 
DW-MRI  were  84.9%  and  94.3%, 
respectively.  The  mean  apparent  diffusion 
coefficient  values  of  IDC  (invasive  ductal 
carcinoma)  and  NIDC  (noninvasive  ductal 
carcinoma)  were  significantly  different  from 
that of the normal breast. They concluded that 
DW-MRI  may  be  useful  for  detecting  breast 
cancer  in  a  wide  age  group  of  women, 
including young women with dense mammary 
glands (Yoshikawa et al, 2007). This explains 
the  excellent  sensitivity  of  MRI  that  we 
achieved in this study (100%) and the ability 
of MRI, including DWI, to detect the lesions 
which were none visualized in mammography 
particularly in dense breasts. Caroline Habib et al 
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Limitations: 
Although our results are comparable to 
most of the previous studies, still there are a 
few  limitations.  The  number  of  patients 
included  in  the  study  was  limited  by  the 
relatively  short  duration  (2.5  years)  of  the 
study  and  limited  number  of  patients  who 
undergo breast MR examinations and fit to our 
inclusion criteria. This is because of cost factor 
and  relative  lack  of  awareness  regarding 
usefulness of MR imaging for the diagnosis of 
breast cancer. Also the short duration hindered 
the long term follow up of some of the patients 
included in our study. 
CONCLUSION 
MR  imaging  of  breast  is  a  rapidly 
evolving  modality  of  excellent  sensitivity  in 
detection of breast cancer. The basic drawback 
of this modality was low specificity for breast 
malignancy.  However,  multiple  studies 
including this study have shown that with the 
improvement  in  equipment  and  technique 
there is gradual increase in specificity.  
Generally speaking breast MRI is highly 
effective  in  detection  and  characterization  of 
occult  breast  lesions  in  high  risk  population, 
with excellent sensitivity and high specificity. 
This is attributed to the advance in equipment, 
technique, development and implementation of 
interpretation  guidelines  and  development  of 
functional MRI tools which contributed to the 
improving validity of this modality. Also the 
superiority  of  MRI  compared  to 
mammography, which is more evident in high 
risk population, supports the use of MRI as an 
important  tool  in  screening  of  asymptomatic 
high risk women. 
Case (1): 
42  years  old  asymptomatic  female,  with  positive  family  history,  mammography  showed  irregular 
assymetrical densities in both breasts, US identified a suspicious left retroareolar mass. On CE-MRI 
the right breast showed an area of non-mass like enhancement in the UOQ with type I benign curve. 
Left breast showed a prominent retroareolar duct 4.3mm with area of abnormal high signal on T2W 
images and post contrast enhancement  is seen  with  diffusion restriction, the  ADC =0.8, the time 
intensity curves of the lesion were type 2 and 3. The lesions were categorized as Left breast lesion; 
BIRADS 4b, and biopsy was recommended. Right breast lesion; BIRADS III, close follow up was 
recommended. Histopathology revealed left sided IDC. 
 
A                                                                     B 
Fig. 3. A Post-contrast images with fat suppression (T1W TSE post-contrast with SPAIR) showing 
abnormal high signal and post contrast enhancement in left retroareolar lesion within prominent ducts. 
B Dynamic multiphase post-contrast study and Time intensity curves. Left breast tetroareolar lesion 
displaying type 2b curve. Role of MRI in Characterization of Occult Breast Lesions…. 
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Case (2): 
33  years  old  female,  with  positive  family  history  of  breast  cancer,  presented  with  palpable  right 
retroareolar mass, mammography showed no corresponding architectural distortion or lesions among 
the  dense  breast  tissues.  Contrast  enhanced  MRI  revealed  right  retroareolar  benign  looking  mass 
BIRADS II. Follow up was done 6 months later which confirmed benign nature. 
 
 
 
Fig. 4. Dynamic multiphase post-contrast study done in 8 minutes with MIP reconstruction and Time 
intensity curves. The kinetic data obtained after calculation of the time intensity curve indicates a 
benign pattern (continuous rising curve with no wash out), type 1 curve. 
 
Case (3): 
32 years old female presented by enlarged left axillary lymph nodes; mammography showed diffuse 
increased breast density, no definite masses could be identified among the dense breast parenchyma. 
US showed enlarged left axillary lymph nodes with a query area of architectural distortion in the left 
breast. CE-MRI revealed bilateral prominent glandular tissue in keeping with pattern of fibroadenosis. 
The left breast showed a small (about 1 cm) rounded retroareolar fibroadenoma. Another rounded 
rather ill defined lesion was detected showing arterial enhancement in the dynamic phases with type II 
curve.  It  showed  corresponding  diffusion  restriction  on  DW  images  with  ADC  value  0.9x10-3 
mm/sec. This indicates suspicious enhancing lesion in the left breast. The left axilla shows two large 
rounded lynph nodes with low signal on T1 and high signal on T2W images, with peripheral rim 
enhancement. Another deeper lymph node was seen with homogenous enhancement of postcontrast 
T1 weighted images. These showed diffusion restriction on DW images with ADC values 1.18x10-
3mm/sec & 0.6x10-3mm/sec respectively the latter shows rapid upslope and washout. The left breast 
was categorized as BIRADS IV b due to the area of mass like architectural distortion with multiple 
large  left  axillary  adenopathies  of  suspicous  features.  Histopathology  confirmed  malignant  nature 
(Invasive Lobular Carcinoma). 
 
 
        A                                                                 B 
Fig.  5.  Dynamic  post-contrast  images  with  fat  suppression  and  MIP  reconstruction  showing;  left 
breast ill-defined enhanced mass like area at 4 o’clock position, homogenously enhanced retroareolar 
fibroadenoma (A) and enlarged left axillary lymph nodes displaying rim enhancement (B). 
 Caroline Habib et al 
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Case (4): 
58 years old asymptomatic female, with past history of left lumpectomy of a malignant lesion 3 years 
ago, presented for follow up. Mammography revealed an area of query irregular asymmetric density 
at right UOQ. CE-MRI revealed an Irregular ill-defined right breast none-mass like lesion at upper 
outer  quadrant.  The  lesion  showed  rather  speculated  margin  with  radiating  striation.  It  showed 
significant post contrast enhancement with type III time/intensity curve (consistent with malignant 
mass), similar adjacent smaller lesions are seen in vicinity (satellites). One large globular lymph node 
was seen on the right. Right breast none-mass like area of abnormal enhancement was categorized as 
BIRADS IV with suspicious right axillary lymph node. Histopathology confirmed malignancy IDC. 
 
 
A                                       B                                        C 
Fig. 6. (A&B) Dynamic post-contrast images of right breast with fat suppression showing; right UOQ 
area of abnormal none-mass like enhancement and enhancing right axillary lymph node. (C) Post-
contrast images of right breast with MIP reconstruction showing hypervascular right UOQ ill-defined 
lesion and right axillary lymph node. 
 
Case (5): 
57 years old female  with past history  of right UIQ and  left  UOQ lumpectomies and  left axillary 
evacuation. Left lesion was IDC, while right lesion was benign. Follow up mammography was done 
and showed right UIQ and left UOQ irregular asymmetric densities. CE-MRI revealed right upper 
inner and left upper outer quadrant encysted postoperative collection exhibiting bright signal in T2 & 
STIR. The lesions showed marginal enhancement and the kinetic data obtained from the lesion after 
the dynamic time intensity curves indicates a benign pattern of curves (continuous rise and no wash 
out) type 1  curves.  They were diagnosed as bilateral postoperative seromas, categorized as BIRADS 
3. Ultrasound guided aspiration and follow up confirmed benign nature. 
 
 
       A                                                                    B  
 
Fig. 7. (A) Dynamic time intensity curves of the right UIQ lesion marginal enhancement displaying 
benign type I curves. (B) Dynamic time intensity curves of the left UOQ lesion marginal enhancement 
displaying benign type I curves. 
 Role of MRI in Characterization of Occult Breast Lesions…. 
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فيصوت   ضارمأ    يدثلا ل ةضماغلا  ناكسل ةريبك ةجردب ةباصلإا رطخل نيضرعملا  
بيبح نيلوراك   روصنم ماشه ،      ،   نسح نسحم   يهاربإ نميأ ، م .  
 ةعشلأا مسق  ،بطلا ةيلك ، سمش نيع ةعماج .  
 
 صخلملا :  
هلا ــــــ فد  :  
 زييمتلا يف يدثلل يسيطانغملا نينرلاب صيخشتلا ةحص مييقت لا يدثلا ضارمأ نيب ةديمح    يدثلا ضارمأو
 ةثيبخلا  ءاسنلا يف ضارمأو ،    يدثلا   غلا ضما لل ة  نيذ  ةيضرعم اونوكي ةيلاع رطاخمل    ،يدثلا ناطرسب ةباصلإل
 و ةيجيسنلا جئاتنلا عم  / ا ةعباتم وأ لا يعجرم رايعمك مادختس  .  
 
قرطلاو ىضرملا  :  
 ىلع يسيطانغملا نينرلاب ريوصتلا ءارجإ مت ةيئانثلا يدثلا ةنسحم نيابتلا 011    نم ريبك رطخ يف ةأرما
 ةددحم ريغ ةطساوب ريوصتلا جئاتن عم يدثلا ناطرسب ةباصلاا  /  قوف تاجوملا وأ يدثلل يعاعشلا ريوصتلاو
ةيتوصلا .  
   ةثيبخلا مارولأا لثمت نأ نكمي يتلا يسيطانغملا نينرلاب ريوصتلا ةطساوب اهنع فشكلا تافلآا مييقت ىرجو
نييدثلا لاك يف ةلمتحملا  .  
 ةيكرحلا ليلحتو مييقت ةيلكشلا تيرجأ (  تقولاو نيابتلا زيزعت  / تاينحنملا ةدش  )  ةفآ لك ىلع  ليلحت مادختساب
ضرعلا جماربو ينافتملا لمعلا جئاتن .  
  يف ةيفيظو تاودأ تمدختساو  MR   يلاوح 01  ةثيبخلا نيب يقيرفتلا صيخشتلا يف ةدعاسملل تلااحلا نم ٪
ةيديلقتلا يسيطانغملا نينرلاب ريوصتلا نع فشكلا يف ةهوبشملا تافلآا نم ةديمحلاو  .  ناك 60  صيخشت مت ٪
 نيب اريخأ 011    ضيرم يف ةجردملا  study12 ٪    يف ،ةديمح جئاتنو ،ضارمأ يأ نم ةيلاخ امك ىضرملا نم
 نأ نيح 10 ةثيبخلا اوناك ىضرملا نم ٪  
  جئاتنلا :    
( 42  IDC  ،  4   ،ةيزاغلا ناطرس صصفم 0    ،ناطرس عاخنلا 0   و ةينيسوم ناطرس DCIS 1).   تناكو
لل ةيبلسلاو ةيباجيلإا ةيؤبنتلا ميقلاو ،ةيعونلاو ،ةيساسحلا CE-MRI  ، 100  ،٪ 93  ،٪ 86  ،٪ 100 ٪    ىلع
 يلاوتلا  . يدثلا ةقد ناكو  MRI  لل ماعلا 56 ٪  . ةصلاخلا  :  ةياغلل ةلاعف وه يدثلا يسيطانغملا نينرلاب ريوصتلا
ةيلاع ةيعونو ةزاتمم ةيساسح عم ،ةيلاع رطاخمل ناكسلا ددع يف ضماغ يدثلا تافآ فيصوتو فشك يف  .
غملا نينرلاب ريوصتلا تاودأ ريوطت مهاس ةقيرطلا هذه ةحص نيسحتل يفيظولا يسيطان .  
 